Pathogenesis of columnar-lined esophagus

被引：5

作者：

Bani-Hani, Kamal E. ^{[1
]}

Bani-Hani, Bayan K. ^{[1
]}

机构：

[1] Jordan Univ Sci & Technol, Fac Med, Dept Surg, Irbid 22110, Jordan

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2006年 / 12卷 / 10期

关键词：

Barrett's esophagus; risk factors; esophageal adenocarcinoma; pathogenesis; reflux esophagitis; gastroesophageal reflux;

D O I：

10.3748/wjg.v12.i10.1521

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Since its initial description, the pathogenesis of the columnar-lined esophagus (CLE) has been surrounded by many controversies. The first controversy is related to the existence of the condition itself. The second controversy centers on whether the CLE is a congenital or an acquired condition. In this article, we review the congenital and acquired theories of development of CLE and discuss the various factors in acquisition of CLE. The bulk of evidence in the literature suggests that CLE is an acquired condition. (C) 2006 The WJG Press. All rights reserved.

引用

页码：1521 / 1528

页数：8

共 50 条

[31] Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia [J].

Groisman, GM ;

Amar, M ;

Meir, A .

MODERN PATHOLOGY, 2004, 17 (10) :1282-1288

[32] Columnar lined (Barrett's) esophagus: Future perspectives [J].

Bani-Hani, Kamal E. ;

Bani-Hani, Bayan K. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (02) :178-191

[33] Letter: cancer risk among persons with columnar-lined oesophagus [J].

Lenglinger, J. ;

Riegler, M. ;

Schoppmann, S. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (06) :599-599

[34] Are newly diagnosed columnar-lined oesophagus patients getting younger? [J].

Wall, Christine M. ;

Charlett, Andre ;

Caygill, Christine Pauline Joan ;

Gatenby, Piers A. C. ;

Ramus, James R. ;

Winslet, Marc C. ;

Watson, Anthony .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (10) :1127-1131

[35] Assessment of columnar-lined esophagus in controls and patients with gastroesophageal reflux disease with and without proton-pump inhibitor therapy [J].

I. Mesteri ;

J. Lenglinger ;

L. Beller ;

S. Fischer-See ;

Sebastian F. Schoppmann ;

F. Wrba ;

F. M. Riegler ;

J. Zacherl .

European Surgery, 2012, 44 :304-313

[36] Assessment of columnar-lined esophagus in controls and patients with gastroesophageal reflux disease with and without proton-pump inhibitor therapy [J].

Mesteri, I. ;

Lenglinger, J. ;

Beller, L. ;

Fischer-See, S. ;

Schoppmann, Sebastian F. ;

Wrba, F. ;

Riegler, F. M. ;

Zacherl, J. .

EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2012, 44 (05) :304-313

[37] Review on novel concepts of columnar lined esophagus [J].

Lenglinger, Johannes ;

See, Stephanie Fischer ;

Beller, Lukas ;

Cosentini, Enrico P. ;

Asari, Reza ;

Wrba, Fritz ;

Riegler, Martin ;

Schoppmann, Sebastian F. .

WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (19-20) :577-590

[38] Cyclooxygenase-2 expression and cell proliferation are increased in MUC2-positive area of columnar-lined esophagus [J].

Jang, TJ ;

Cho, MY .

PATHOLOGY INTERNATIONAL, 2005, 55 (09) :546-549

[39] Pediatric Columnar Lined Esophagus vs Barrett's Esophagus: Is It the Time for a Consensus Definition? [J].

Cohen, Marta C. ;

Ashok, Dhandapani ;

Gell, Mark ;

Bishop, John ;

Walker, Jenny ;

Thomson, Mike ;

Al-Adnani, Mudher .

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2009, 12 (02) :116-126

[40] DOES SHORT-SEGMENT COLUMNAR-LINED ESOPHAGUS ELONGATE DURING A MEAN FOLLOW-UP PERIOD OF 5.7 YEARS? [J].

Manabe, Noriaki ;

Haruma, Ken ;

Imamura, Hiroshi ;

Kamada, Tomoari ;

Kusunoki, Hiroaki ;

Inoue, Kazuhiko ;

Shiotani, Akiko ;

Hata, Jiro .

DIGESTIVE ENDOSCOPY, 2011, 23 (02) :166-172

← 1 2 3 4 5 →